Developing an algorithm for the management of Renal Cell Carcinoma: focus on metastatic disease

The treatment paradigm in renal cell carcinoma (RCC) is rapidly changing. The incidental finding of small renal tumours combined with the development of novel therapeutic agents targeting the vascular endothelial growth factor (VEGF) or the mammalian target of rapamycin (mTOR) pathways or inhibiting...

Full description

Bibliographic Details
Main Authors: Kyriazoglou Anastasios, Dimitriadis Ioannis, Bamias Aristotelis
Format: Article
Language:English
Published: Sciendo 2017-06-01
Series:Forum of Clinical Oncology
Subjects:
Online Access:https://doi.org/10.1515/fco-2015-0025
_version_ 1818191878402605056
author Kyriazoglou Anastasios
Dimitriadis Ioannis
Bamias Aristotelis
author_facet Kyriazoglou Anastasios
Dimitriadis Ioannis
Bamias Aristotelis
author_sort Kyriazoglou Anastasios
collection DOAJ
description The treatment paradigm in renal cell carcinoma (RCC) is rapidly changing. The incidental finding of small renal tumours combined with the development of novel therapeutic agents targeting the vascular endothelial growth factor (VEGF) or the mammalian target of rapamycin (mTOR) pathways or inhibiting the interaction of the programmed death 1 (PD 1) receptor with its ligand have dramatically improved the prognosis of patients suffering from this malignancy. At the same time, the availability of multiple effective options with similar indications complicates the development and applicability of guidelines in this disease. We conducted a systematic review of the existing guidelines. Our study revealed areas of agreement as well as of discrepancies amongst the published scientific papers included. By critically evaluating these areas, we developed a therapeutic algorithm for RCC. We suggest that this methodology can define the practices of wide applicability and areas of future research.
first_indexed 2024-12-12T00:21:36Z
format Article
id doaj.art-4f3bc5cc852a4b62ae652c42167541a5
institution Directory Open Access Journal
issn 1792-362X
language English
last_indexed 2024-12-12T00:21:36Z
publishDate 2017-06-01
publisher Sciendo
record_format Article
series Forum of Clinical Oncology
spelling doaj.art-4f3bc5cc852a4b62ae652c42167541a52022-12-22T00:44:43ZengSciendoForum of Clinical Oncology1792-362X2017-06-0181152110.1515/fco-2015-0025fco-2015-0025Developing an algorithm for the management of Renal Cell Carcinoma: focus on metastatic diseaseKyriazoglou Anastasios0Dimitriadis Ioannis1Bamias Aristotelis2General Hospital Alexandra, Athens, GreeceGeneral Hospital Alexandra, Athens, GreeceGeneral Hospital Alexandra, Athens, GreeceThe treatment paradigm in renal cell carcinoma (RCC) is rapidly changing. The incidental finding of small renal tumours combined with the development of novel therapeutic agents targeting the vascular endothelial growth factor (VEGF) or the mammalian target of rapamycin (mTOR) pathways or inhibiting the interaction of the programmed death 1 (PD 1) receptor with its ligand have dramatically improved the prognosis of patients suffering from this malignancy. At the same time, the availability of multiple effective options with similar indications complicates the development and applicability of guidelines in this disease. We conducted a systematic review of the existing guidelines. Our study revealed areas of agreement as well as of discrepancies amongst the published scientific papers included. By critically evaluating these areas, we developed a therapeutic algorithm for RCC. We suggest that this methodology can define the practices of wide applicability and areas of future research.https://doi.org/10.1515/fco-2015-0025renal cell carcinomametastatic diseasetherapeutic algorithm
spellingShingle Kyriazoglou Anastasios
Dimitriadis Ioannis
Bamias Aristotelis
Developing an algorithm for the management of Renal Cell Carcinoma: focus on metastatic disease
Forum of Clinical Oncology
renal cell carcinoma
metastatic disease
therapeutic algorithm
title Developing an algorithm for the management of Renal Cell Carcinoma: focus on metastatic disease
title_full Developing an algorithm for the management of Renal Cell Carcinoma: focus on metastatic disease
title_fullStr Developing an algorithm for the management of Renal Cell Carcinoma: focus on metastatic disease
title_full_unstemmed Developing an algorithm for the management of Renal Cell Carcinoma: focus on metastatic disease
title_short Developing an algorithm for the management of Renal Cell Carcinoma: focus on metastatic disease
title_sort developing an algorithm for the management of renal cell carcinoma focus on metastatic disease
topic renal cell carcinoma
metastatic disease
therapeutic algorithm
url https://doi.org/10.1515/fco-2015-0025
work_keys_str_mv AT kyriazoglouanastasios developinganalgorithmforthemanagementofrenalcellcarcinomafocusonmetastaticdisease
AT dimitriadisioannis developinganalgorithmforthemanagementofrenalcellcarcinomafocusonmetastaticdisease
AT bamiasaristotelis developinganalgorithmforthemanagementofrenalcellcarcinomafocusonmetastaticdisease